# Randomised Evaluation of Sodium Dialysate Levels on Vascular Events

> **NCT02823821** · PHASE4 · RECRUITING · sponsor: **University of Sydney** · enrollment: 50000 (estimated)

## Conditions studied

- End-Stage Kidney Disease

## Interventions

- **OTHER:** Default dialysate sodium concentration of 137mmol/l
- **OTHER:** Default dialysate sodium concentration of 140mmol/l

## Key facts

- **NCT ID:** NCT02823821
- **Lead sponsor:** University of Sydney
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2016-06
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 50000 (ESTIMATED)
- **Last updated:** 2025-04-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02823821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02823821, "Randomised Evaluation of Sodium Dialysate Levels on Vascular Events". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT02823821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*